Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
George Werther Insider Profile
4 Followers
George Werther, Director at Antisense Therapeutics Limited, holds 2.57M shares in Antisense Therapeutics Limited (Ticker: ATHJF). Most recently, George Werther ― shares of Antisense Therapeutics Limited on ― for an estimated value of ―.
George Werther has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of George Werther's holdings
Insider Roles
Director
Roles that George Werther holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by George Werther
George Werther's Trading History
List of latest transactions for each holding click on a transaction to see George Werther's performance on stock
You May Also Like
George Werther insider profile FAQ
What is the percentage of profitable transactions made by George Werther?
The percentage of profitable transactions made by George Werther is ―.
What is the average return per transaction made by George Werther?
The average return per transaction made by George Werther is ―.
What stocks does George Werther hold?
George Werther holds: ATHJF stocks.
What was George Werther’s latest transaction?
George Werther latest transaction was an Uninformative Buy of ―.
What was George Werther's most profitable transaction?
George Werther’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is George Werther's role in Antisense Therapeutics Limited?
George Werther's role in Antisense Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.